dc.contributor.author | Smrke, AM | |
dc.contributor.author | Huang, PH | |
dc.contributor.author | Jones, RL | |
dc.date.accessioned | 2021-02-04T15:45:52Z | |
dc.date.available | 2021-02-04T15:45:52Z | |
dc.date.issued | 2020-10-27 | |
dc.identifier.citation | Cancer, 2020 | |
dc.identifier.issn | 0008-543X | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/4335 | |
dc.identifier.eissn | 1097-0142 | |
dc.identifier.doi | 10.1002/cncr.33246 | |
dc.description.abstract | Epithelioid hemangioendothelioma is an ultrarare soft tissue sarcoma with limited literature to guide treatment. The results from a robust retrospective cohort study support the use of sirolimus for patients who have multifocal epithelioid hemangioendothelioma without serosal effusion. | |
dc.format | Print-Electronic | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | WILEY | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.title | Sirolimus for patients with progressive epithelioid hemangioendothelioma. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2020-09-12 | |
rioxxterms.version | VoR | |
rioxxterms.versionofrecord | 10.1002/cncr.33246 | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0 | |
rioxxterms.licenseref.startdate | 2020-10-27 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Cancer | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Molecular and Systems Oncology | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Molecular and Systems Oncology | |
pubs.publication-status | Published | |
pubs.embargo.terms | Not known | |
icr.researchteam | Molecular and Systems Oncology | |
icr.researchteam | Molecular and Systems Oncology | |
dc.contributor.icrauthor | Huang, Paul | |